RC
ACET icon

RBF Capital’s Adicet Bio ACET Stock Holding History

RBF Capital’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Hold
38,582
– – 0.01% 431
2026
Q1 		$263K Hold
38,582
– – 0.01% 434
2025
Q4 		$325K Hold
38,582
– – 0.01% 460
2025
Q3 		$500K Hold
38,582
– – 0.02% 406
2025
Q2 		$377K Hold
38,582
– – 0.02% 459
2025
Q1 		$466K Buy
38,582
+1,011
+3% +$14.5K 0.03% 398
2024
Q4 		$578K Hold
37,571
– – 0.03% 368
2024
Q3 		$866K Buy
37,571
+14,446
+62% +$323K 0.04% 317
2024
Q2 		$448K Buy
+23,125
New +$620K 0.03% 409

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

RBF Capital's ACET Position: Q2 2026 in Review

RBF Capital held its Adicet Bio (ACET) position steady in Q2 2026 at 38,582 shares worth $333K. The position accounts for 0.01% of the portfolio, ranked #431.

RBF Capital first reported a position in ACET in Q2 2024 and has held it in 9 quarters since. The position peaked at $866K in Q3 2024. 56 funds tracked by Wall St. Rank hold ACET as of Q2 2026.

  • RBF Capital held 38,582 shares of Adicet Bio worth $333K as of Q2 2026.
  • RBF Capital left its Adicet Bio share count unchanged in Q2 2026.
  • Adicet Bio made up 0.01% of RBF Capital's portfolio in Q2 2026, its #431 holding.
  • RBF Capital first reported a position in Adicet Bio in Q2 2024 and has held it in 9 quarters since.
  • RBF Capital's Adicet Bio position peaked at $866K in Q3 2024.
  • 56 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2026.

Based on RBF Capital's 13F filing for Q2 2026, filed 14 Aug 2026.